D03.121
Melanoma in situ of left upper eyelid, including canthus
Clinical Classification Guidelines
Medical Intelligence & Overview
Melanoma in situ of the left upper eyelid, including the canthus, is a form of early-stage skin cancer that affects the pigmented cells of the eyelid. As a condition confined to the top layer of the skin, it has not yet invaded deeper tissues. Recognizing and understanding this diagnosis is crucial for timely management and treatment, which can prevent progression to invasive melanoma.
Causes & Symptoms
Clinical Causes: Excessive exposure to ultraviolet (UV) radiation from the sun or tanning beds Having fair skin that is more susceptible to sun damage A history of sunburns or significant sun exposure over time Presence of numerous moles or atypical moles Family history of melanoma or other skin cancers Weakened immune system that reduces the body's ability to detect and fight abnormal cells
Key Symptoms: The appearance of a new or changing pigmented spot or lesion on the eyelid A flat, irregularly shaped, or pigmented lesion that may be slightly elevated Lesion with uneven borders or multiple shades of brown, black, or pigment Presence of crusts, bleeding, or ulceration in the affected area Localized swelling, tenderness, or a sensation of a lump at the site Changes in eyelid pigmentation, shape, or texture over time
Diagnostic & Treatment
Diagnosis Path: Diagnosis often begins with a thorough ocular and dermatological examination of the eyelid. A dermatologist or ophthalmologist may perform the following steps:
Treatment Protocols: Treatment options aim to completely remove the melanoma in situ and preserve eyelid function and appearance, which may include:
Clinical Advice & FAQs
Billing Guidance
Is D03.121 a billable ICD-10 code?
Yes, D03.121 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D03.121?
Clinical documentation must specify the nature of Melanoma in situ of left upper eyelid, including canthus and any associated comorbidities for accurate reporting.
Cite this Clinical Reference